NDC 72189-218
Np Thyroid 19 ug / 4.5 ug tablet
On the label: Direct Rx. It's repackaged: Direct Rx rebottles it from Acella Pharmaceuticals, LLC's NDC 42192-329.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Acella Pharmaceuticals, LLC names for other drugs.
Repackaging site
- Direct Rx, Dawsonville, GA, United States · repackages it
Recalls
- Apr 29, 2021 · Class I · Acella Pharmaceuticals, LLC
Subpotent Drug
Lots: Lots: a) M329D20-1, M329D20-2, M329D20-3 Exp. 03/31/2022, ; b) M329D20-2 Exp. 03/31/2022 - May 22, 2020 · Class I · Acella Pharmaceuticals, LLC
Superpotent Drug.
Lots: Lots: M329H18-1, Exp. JUL-2020; M329J18-1, M329J18-2, M329J18-3 Exp. AUG-2020; M329M18-2 Exp. NOV-2020, M329A19-1 Exp. DEC-2020.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Levothyroxine and Liothyronine: every company that makes it
- Form
- tablet, oral
- Strength
- 19 ug / 4.5 ug
- Approval
- unapproved drug other
- On the market since
- May 11, 2021
- Package NDCs
72189-218-90- Official label
- DailyMed (National Library of Medicine), updated Jan 20, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?